Learn about DARZALEX FASPRO® + VRd, the latest FDA-approved quad treatment combination for people with newly diagnosed multiple myeloma who are not eligible to receive a stem cell transplant
DARZALEX FASPRO ® is now FDA approved as the first therapy for use alone to treat adults with high-risk smoldering multiple myeloma.
If you or a loved one have been diagnosed with multiple myeloma, you may have questions or concerns. The links below can offer a quick summary of medical information to make things easier to understand. Here you can learn more about: